David Stadnyk, chairman of (), speaks to Proactive London as the CBD and medicinal cannabis investment firm begins trading on London's NEX exchange.
Stadnyk says they're currently assessing a number of investment opportunities in the medicinal cannabis, hemp and CBD sectors.
He adds that the global CBD market is set to increase from $270mln this year to $3.86bn by 2025, with the global medical cannabis market forecast to reach $148.35bn by 2026.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...
FOR OUR FULL DISCLAIMER CLICK HERE